Lantern Pharma Inc. (LTRN)
NASDAQ·Healthcare·Biotechnology
$2.20
-10.77%
Mkt Cap $29.86M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$0.46 | -$0.36 | +21.74% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.46 | -$0.39 | +15.22% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.53 | -$0.40 | +24.53% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.49 | -$0.42 | +14.29% | — | — |
| Q1 2025 Mar 27, 2025 | — | $100.65K | — | -$0.51 | -$0.54 | -5.88% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.56 | -$0.42 | +25.00% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.55 | -$0.46 | +16.36% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.43 | -$0.51 | -18.60% | — | — |
| Q1 2024 Mar 18, 2024 | — | $261.05K | — | -$0.40 | -$0.39 | +2.50% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$0.45 | -$0.29 | +35.56% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$0.43 | -$0.44 | -2.33% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.48 | -$0.36 | +25.00% | — | — |
| Q1 2023 Mar 20, 2023 | — | — | — | -$0.47 | -$0.31 | +34.04% | — | — |
| Q4 2022 Nov 7, 2022 | — | — | — | -$0.48 | -$0.21 | +56.25% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.52 | -$0.41 | +21.15% | — | — |
| Q2 2022 May 3, 2022 | — | — | — | -$0.29 | -$0.38 | -31.03% | — | — |
| Q1 2022 Mar 10, 2022 | — | — | — | -$0.40 | -$0.32 | +20.00% | — | — |
| Q4 2021 Nov 1, 2021 | — | — | — | -$0.27 | -$0.36 | -33.33% | — | — |
| Q3 2021 Jul 29, 2021 | — | — | — | -$0.26 | -$0.21 | +19.23% | — | — |
| Q2 2021 May 3, 2021 | — | — | — | -$0.27 | -$0.24 | +11.11% | — | — |